ctrf leadership meeting
DESCRIPTION
CTRF Leadership Meeting. Cancer Genomics and Development. of Diagnostic Tools and Therapies. April 1, 2002. Institutional Partners. Develop Infrastructure and Intellectual Property that Enhance s the Competitiveness of the Partners for Clinical and Extramural Funds. - PowerPoint PPT PresentationTRANSCRIPT
CTRF Leadership Meeting
April 1, 2002
Institutional Partners
Develop Infrastructure and Intellectual Property that
Enhances the Competitiveness of the Partners for Clinical and
Extramural Funds
Principle Objective
Evaluate gene expression (and genetic changes) in human brain, ovarian, breast and hematopoetic cancers
Link gene expression (and genetic changes) to clinical findings and clinical laboratory findings (including histopathological diagnoses) in a common database
Evaluate linked data using bioinformatics
Research Objective
ChandhokeGrant
ChristensenFryxell
Jamison
Torr (Central Admin)GinderGarrettBuck
Guiseppe-ElieAbraham
Cooper
Year 1 Year 1 Year 1
$325,000 $582,000 $93,000
Total (3 yrs) Total (3 yrs) Total (3 yrs)
$975,000 $1,734,603 $290,397
Funding From CTRF
CTRF Funding - Monitoring Expenses
$ Data acquired from two accounting sources (Focus & FRS)
$ Need to identify keys to link data sets$ Automating data acquisition and
linkage remains major challenge
Reminder - Cost Share Form (VCU)
Cost share expenditures not paid from cost share linked ledger 4 account must be documented using ‘In Kind/3rd Party Cost Share form’ obtained from Margie Booker’s office.
CTRF Funding
CTRF Budget Reductions
• Budget passed by the General Assembly reductions in the CTRF of $1.25 million for 2003 and $1.5 million for 2004 (9% and 19%)
• This is not yet the final budget - the final version will not be passed until the April 17 reconvened session
CTRF Budget Reductions
• DPB gathering information for the Governor on the potential impact of these reductions.
• Any details you can provide about specific implications - how a reduction of this magnitude would affect your project, the impact on agreements you have in place with industry or academic partners, or on personnel you have brought on board - will be helpful in clarifying the consequences of a reduction in funding for existing projects.
• Please send this information by early next week if at all possible.
Website Update
Website is up and running; site is under construction
The URL for site is www.ctrf-cagenomics.vcu.edu
Content is still needed
Completion of site by mid April
Website Update - Home Page
Website Update - PI Page
Website Update - Focus Groups Page
Website Update - Focus Groups Page
SPIN Research
Jo Ann Breaux receiving daily notices of grant opportunities
Compiling weekly document of relevant findings
Will be distributed over the CTRF LISTSERV
1. Breast Cancer Research Program--Exploration Awards2. Breast Cancer Research Program--Physician-Scientist Training Awards3. Breast Cancer Research Program--Biotechnology Clinical Partnership Awards4. Breast Cancer Center of Excellence Awards5. Breast Cancer Research Program--HBCU/MI Partnership Training Awards6. Breast Cancer Research Program--Collaborative-Clinical Translational
Research Awards7. Ovarian Cancer Research Program--Institutional Training Grants8. Ovarian Cancer Research Program--Idea Development Awards9. RFP--Department of Defense Prostate Cancer Research Program (PCRP) for
Fiscal Year 200210. NCI--Specialized Programs of Research Excellence (SPOREs) in Pancreatic
Cancer for the Year 200211. NCI--Institutional Clinical Oncology Research Career Development Program12. NCI--Cancer Education and Career Development Program13. NHGRI--Technologies for Genomic Mapping, Sequencing & Analysis Program14. NHGRI--Pilot Projects or Feasibility Studies for Genomic Analysis15. RFA-HG-02-002--Developing Robust Components for Model Organism
Databases16. RFA-LM-02-001--NLM Internet Access to Digital Libraries Grants17. AHRQ--AHRQ Health Services Research18. Partnerships for Innovation (PFI)
SPIN Research
Tissue Bank Clinical and Pathology Laboratory
Data Database Design Data Analysis Quality Assurance in Microarray
Analysis (Chip Fabrication - proposed)
Focus Group
Focus Group Leaders
GMU
G e rald in e G ran t ( G M U )S u ha il N as im ( V C U )B a rr ie C o o k ( I n o va)
Tissue Bank
L yn ne P en b e rth y (V C U )S u ha il N as im ( V C U )
J a m e s C o op e r ( I n o va)J a m e s B u rge s s ( I no va)
B a rr ie C o o k ( I n o va)
C linP ath
C u rtis J am is on ( G M U )L yn ne P en b e rth y (V C U )
G re g M ille r (V C U )M ike S he ride n ( I no va)
D B D esign
V ika s C h an d h oke ( G M U )G re g B u ck ( V C U )
D ataA nalysis
A la n C h r is ten s en ( G M U )A n d re a F e rre ira - G o n z ale z (V C U )
Q A / LQ C
VCU I nova
Focus Group Leaders
• Meeting March 5, 2002 at Inova
• Tissue Acquisition person to be hired and managed by Marianne Smith
– Inova to work out process for obtaining necessary informed consent
• Tissue Bank person to go to OR area with pathologist responding to request for frozen section and take tissue at that time
• Ideal procedure is unclear at this time for tissue acquisition unclear:
– Cut and freeze a piece of tissue at the OR (most rapid)
– Perform a frozen section on a block and then drop the latter into liquid nitrogen (delat 5-10min)
• Protocol handling for Bone Marrow Aspirates not yet specified
• Tissue is not to leave Inova until surg path written report is completed
CTRF - Tissue Bank
CTRF - Tissue Bank
• Tissue Acquisition Protocol - Reviewed by VCU IRB - minor revisions requested (approval anticipated by May)
• Tissue Bank Staff Activities (Cynthia Losco)
– Improving current tissue storage system
– Meeting with pathologists and MCC faculty
• tissue handling
• breast clinic scheduler
– Developing expertise at cutting frozen section and microdissection
– developing database fields necessary for Tissue Bank
• Attending weekly Breast Conference to identify potential cases
• Data Sources– Clinical - MCCIS, Pathology, INOVA
• Desirable Info - Contains financial treatment and outcomes• If clinical identifiers present, must be behind firewall• Histopathology currently text format only
– Microarray Data
• Data Warehouse– Initial plan - include extensive clinical information including
therapies– ?Role of hypothesis’ in design of functional data warehouse
Database Design/Clinical InfoDatabase Design Meeting at GMU
(3/6/02)
Database Design/Clinical Info
Test Installation of GeneX up and Running (3/5/02)
Created And Instantiated A Schema For A Row-modeled Clinical Database (3/5/02)
Creating A Linking Table To Span The Two Databases (3/5/02)
GMU
Database Design/Clinical InfoVCU
MCC Registry (ERS) New system with cross platform connectivity ERS Company interested in assisting in data transfer issues
Pathology Shadow Database Contains all Pathology reports in text format and SNOMED
codes SNOMED Accuracy - an issue
Examined 95 breast cases accessioned 12/11/01-1/16/02 1 of 48 cases with cancer not coded for malignancy 9 cases coded as infiltuating duct but actually DCIS Other problems Automatic coding system and changes to dictionary planned
with expected improvement of accuracy
“Terabyte” Database - Questions associated analysis tools access issues capacity for incorporating clinical data advantages over open source databases
such as Gene-X
Data Analysis
GMU
Data Analysis
GeneX Database Set up at both institutions associated analysis tools ?status regarding Affymetrix Data
compatibility platform compatibility (?Unix based
only)
VCU
Meeting with Focus Group took place on March 21st
Major issues Quality Parameters needed to judge integrity of
tissue, RNA, and within platform and cross platform performance
Tissue Quality - percent tumor (frozen section); specimen handling - time to freezing; RNA integrity and changes in gene expression
RNA Quality - integrity (electropherogram); labeling; quantitation (real-time PCR)
Reference Material Commercial RNA prep (Dr. Christensen); other
QA/QC
Establish Standing Weekly or Biweekly Meeting Dates and Times
Complete the Milestone Updates
Document Discussions and Progress Using Listservs
REMINDER
CG-TISBK: Tissue Bank CG-CLNDT: Clinical and Pathology Data CG-DBDSN: Database Design CG-ANLDT: Analyze Data (Data Analysis) CG-QAQC: QAQC CG-LDRPI: Focus Group Leaders and PIs CG-MEMBS: All Members
Communication Amongst Members and
Focus Groups
Address messages to: [email protected]
Unsubscribe to the listserv by submitting a message with the words SIGNOFF listname to: [email protected]
Subscribe to the listserv by asking the PI with whom you work to submit your name and E-mail address to the Program Director (C.Garrett)
USE the listserv(s) to inform members of your activity or to seek advice from the members.
LISTSERVS
Old Business
New Business
Intellectual property reporting - licenses, patents, etc
Publications
New applications identified - CTRF Administrative office
will search for new funding opportunities (SPIN)
will collect CVs, other support, facilities, interest documents
goal - 4 - 8 million in d.c. from CTRF CG Project
Any other discoveries
Federal money leveraged
Private research money leveraged
Advancement of technology and economic development in VA
CTRF - Specific Reportables
- - Reminder - -
Monday
May 6, 2002
9:30 am